Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$38.15 - $57.1 $11,445 - $17,130
300 Added 4.68%
6,715 $274,000
Q2 2022

Aug 09, 2022

SELL
$33.54 - $55.0 $122,085 - $200,200
-3,640 Reduced 36.2%
6,415 $353,000
Q1 2022

May 10, 2022

SELL
$31.02 - $48.18 $8,995 - $13,972
-290 Reduced 2.8%
10,055 $365,000
Q4 2021

Feb 11, 2022

SELL
$41.14 - $56.98 $33,734 - $46,723
-820 Reduced 7.34%
10,345 $482,000
Q3 2021

Nov 12, 2021

BUY
$35.31 - $50.56 $17,655 - $25,280
500 Added 4.69%
11,165 $565,000
Q2 2021

Aug 12, 2021

SELL
$25.8 - $41.09 $48,168 - $76,715
-1,867 Reduced 14.9%
10,665 $438,000
Q1 2021

May 14, 2021

BUY
$23.55 - $32.4 $121,518 - $167,184
5,160 Added 69.99%
12,532 $364,000
Q4 2020

Feb 12, 2021

SELL
$25.8 - $32.39 $15,738 - $19,757
-610 Reduced 7.64%
7,372 $208,000
Q3 2020

Nov 12, 2020

BUY
$27.5 - $39.61 $52,800 - $76,051
1,920 Added 31.67%
7,982 $246,000
Q2 2020

Aug 13, 2020

BUY
$36.1 - $42.56 $218,838 - $257,998
6,062 New
6,062 $258,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Cna Financial Corp Portfolio

Follow Cna Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cna Financial Corp with notifications on news.